No Data
No Data
Revelation Biosciences Completes Enrollment And Dosing In First Human Phase 1 Study Of Gemini; Top-Line Data To Include Safety, Tolerability, And Biomarkers; Supports Future Development Across Multiple Indications
Revelation Biosciences Completes Enrollment And Dosing In First Human Phase 1 Study Of Gemini; Top-Line Data To Include Safety, Tolerability, And Biomarkers; Supports Future Development Across Multipl
12 Health Care Stocks Moving In Friday's After-Market Session
GainersAkso Health Group (NASDAQ:AHG) shares rose 11.4% to $0.79 during Friday's after-market session. The company's market cap stands at $116.0 million. China SXT Pharmaceuticals (NASDAQ:SXTC) shares
Express News | Revelation Biosciences Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 EPS Results
Express News | Revelation Biosciences Inc: Believes That Its Current Cash and Cash Equivalents Are Sufficient to Fund Operations Through 2024.
Express News | Revelation Biosciences, Inc. Announces Financial Results for the Three Months Ended March 31, 2024
Express News | Revelation Biosciences Inc. Q1 EPS USD -2.46
No Data